RxDoctor Payments Data

M Abbasi, MD

Psychiatry · Newton, NJNPI 1316591258

Payments from drug & device makers

$299in general payments, 2019–2025

Across 12 payments — averaging $24.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$112
  • Alkermes, Inc.$49
  • Bioxcel Therapeutics, Inc.$28
  • Indivior Inc.$28
  • Spectrum Pharmaceuticals Inc.$21
  • Otsuka America Pharmaceutical, Inc.$19
  • plus $42 from 3 others

What the payments were for

  • Food & beverage$299100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$299 in reported general payments places this provider in the 55th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey

Medicare billing

Part B allowed, 2024
$50,716
Medicare patients
200
Services billed
403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole12$34,016
ClozarilClozapine11$21,342
Lurasidone Hcl40$18,130
VraylarCariprazine Hcl14$17,761
Aripiprazole95$7,290
Clozapine112$7,183
Clomipramine Hcl33$6,631
Bupropion XlBupropion Hcl117$3,658
Divalproex Sodium ErDivalproex Sodium75$2,713
Quetiapine Fumarate131$2,115
Trazodone Hcl193$2,008
Olanzapine132$1,907
Quetiapine Fumarate ErQuetiapine Fumarate32$1,894
Buspirone Hcl166$1,858
Lamotrigine184$1,766

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$19$34,01612 claims
Almatica Pharma LLCSertraline Hcl$14$757110 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,119 psychiatry providers in New Jersey.

Other psychiatry in Newton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →